Wallace DJ, Ginzler EM, Merrill JT, et al. Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. EULAR 2017, #OP0232.
Nieuwe antistoffen ontwikkeld die ontsteking remmen bij auto-immuunziekten
dec 2025 | Benigne hematologie, RA